Walleye Capital’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4M | Sell |
376,559
-217,631
| -37% | -$812K | 0.01% | 732 |
|
|
2025
Q1 | $1.64M | Buy |
594,190
+475,294
| +400% | +$1.31M | 0.01% | 659 |
|
|
2024
Q4 | $659K | Sell |
118,896
-66,899
| -36% | -$371K | ﹤0.01% | 1067 |
|
|
2024
Q3 | $1.55M | Buy |
+185,795
| New | +$1.55M | ﹤0.01% | 879 |
|
|
2024
Q1 | – | Sell |
-25,295
| Closed | -$164K | – | 2984 |
|
|
2023
Q4 | $164K | Sell |
25,295
-104,811
| -81% | -$680K | ﹤0.01% | 1521 |
|
|
2023
Q3 | $654K | Sell |
130,106
-215,393
| -62% | -$1.08M | ﹤0.01% | 1057 |
|
|
2023
Q2 | $3.02M | Buy |
+345,499
| New | +$3.02M | 0.01% | 402 |
|
|
2023
Q1 | – | Sell |
-73,611
| Closed | -$749K | – | 2699 |
|
|
2022
Q4 | $749K | Buy |
73,611
+61,487
| +507% | +$626K | 0.01% | 823 |
|
|
2022
Q3 | $71K | Buy |
+12,124
| New | +$71K | ﹤0.01% | 1715 |
|